<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The lecture presents modern interpretation of the term "<z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo>" (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) and Montreal classification of this disease with emphasis on non-erosive reflux disease and risk to develop Barret's esophagus which is a widely prevalent precancer condition frequently transforming into esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Description is given of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> causes, mechanisms of development, diagnostic and differential diagnostic signs of the disease, a high risk of <z:hpo ids='HP_0002099'>bronchial asthma</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> patients, basic treatment principles including healthy way of life, pharmacotherapy (antacids, alginates, prokinetics, <z:chebi fb="0" ids="49200">proton pump inhibitors</z:chebi>, etc.) </plain></SENT>
</text></document>